Transcapillary Colloid Osmotic Gradient and Body Fluid Volumes in Renal Failure
Total Page:16
File Type:pdf, Size:1020Kb
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 29 (1986), pp. 895—900 Transcapillary colloid osmotic gradient and body fluid volumes in renal failure PER FAUCHALD Medical Department B, The National Hospital of Norway, Oslo, Norway Transcapillary colloid osmotic gradient andbodyfluid volumes In renal treatment, below which the patient often will suffer sympto- failure. The aim was to study the transcapillary fluid balance in dialysis matic hypotension [6, 7]. patients during and after ultrafiltration. Plasma and subcutaneous The aim of the study was to examine to what extent the interstitial fluid (wick technique) colloid osmotic pressure, plasma volume (I'25-albumin space) and extracellular fluid volume (radiosulfate edema—preventing mechanisms of reduced interstitial colloid space) were measured in nine patients on maintenance hemodialysis osmotic pressure and increased transcapillary colloid osmotic before (pre-dialysis state) and after (dry-weight state) ultraffitration. In gradient are activated in patients with chronic renal failure on the pre-dialysis state, interstitial colloid osmotic pressure was reduced maintenance hemodialysis. A secondary aim was to study the compared to normal controls (12.7 3.5versus 15.8 2.7mmHg, mean values SD) andtranscapillary colloid osmotic gradient increased changes in plasma colloid osmotic pressure and plasma volume (15.3 3.0versus 12.8 2.7mmHg). Ultrafiltration resulted in a during ultrafiltration. In order to accomplish these objectives, parallel decrease of plasma volume and interstitial fluid volume of 19 to colloid osmotic pressure in plasma and interstitial fluid and 20%, and an increase in mean interstitial colloid osmotic pressure of 3.4 body fluid volumes (plasma volume and extracellular fluid mmHg and in mean transcapillary colloid osmotic gradient of 1.9volume) were measured in a pre-dialysis fluid state and after mmHg. The mean ultrafiltration rate was 21.9 1.9mllmin and the plasma refilling rate was 16.5 2.7mI/mm. It is concluded that the ultrafiltration to a dry-weight state. In addition, plasma colloid changes in plasma and interstitial fluid colloid osmotic pressure tend to osmotic pressure was followed during ultrafiltration. preserve plasma volume and limit the interdialytic increase in intersti- tial fluid volume. Material Patients Nine patients (2 females and 7 males, mean age 65.6 years, range of 61 to 70 years old) with chronic renal failure were studied. Patient 1 was anephric and the other patients had Patients with chronic renal failure on maintenancecreatinine clearance less than 5 mI/mm. Diagnosis and clinical hemodialysis commonly show abnormalities in body fluid com-information are given in Table 1. The body weight and the position [1—5]. In addition to increases in extracellular fluidlaboratory values in Table 1 are data from day 1 (before volume, alterations in the partition of volumes between thetreatment). Patient 2 had moderate edema in the ankle region on intravascular and the interstitial spaces are reported in chronicday 1, the other patients did not have edema. None of the renal failure [1, 2, 5]. Intermittent fluid overload and the needpatients had congestive heart failure, nephrotic syndrome, for fluid withdrawal during dialysis frequently create clinicaldiabetes mellitus or liver disease. They were all established on complications [6—8]. Plasma volume depletion is an importanthemodialysis treatment for at least eight weeks and were factor in the pathogenesis of symptomatic hypotension whichinvestigated as outpatients. Six of the patients were treated with occurs in approximately 25% of hemodialysis treatments [6—11].furosemide (mean dosage 590 mg/day, range 160 to 1000 With the tendency to at least intermittent fluid overload,mg/day) and four patients were on antihypertensive treatment activation of local edema—preventing factors [12], such as(Table 1). All medication was continued in unchanged dosage reduced interstitial colloid osmotic pressure, could be expectedduring the investigation. in dialysis patients. Hildebrandt et al [13] recently found Normal subjects Colloid osmotic pressure in plasma and evidence for reduced extravascular albumin mass in patients oninterstitial fluid were measured in 16 normal subjects (four chronic hemodialysis. Reduced subcutaneous interstitial colloidfemales and 12 males, mean ageS! years, range of 33 to 72 years osmotic pressure has been found in patients with fluid overloadold) [14]. Plasma and extracellular fluid volume were measured due to nephrotic syndrome, heart failure and hepatic cirrhosisin another group of 19 normal subjects (11 females and eight [14—16]. males) aged 22 to 54 years (mean 36 years) [14]. Dry weight or ideal weight for a given dialysis patient is Informed consent was obtained in each case. The protocol defined as the weight obtained at the end of hemodialysiswas approved by the Ethical Committee, Norwegian Council for Science and the Humanities. Received for publication April 18, 1985, Methods and in revised form July 8, 1985 Design of the study Plasma and extracellular fluid volume © 1986 by the International Society of Nephrology were measured in the morning under fasting condition and in 895 896 Fauchald Table 1. Clinical and laboratory data of the patientsa. Body Body Serum Serum Serum Duration of Antihypertensive Patient Clinical Age height weight MAP Hct urea creatinine albumine dialysis diuretic no, diagnosis(years)Sex (cm) (kg) (mmHg) (%)(mmolell) (Mmolell) (gil) (months) treatment I TBC 62 M 173 70.5 120 25 22.4 1149 33 12 none 2 CON 70 M 162 76.4 107 31 26.1 415 31 5 F+A 3 NSC 61 M 178 75.0 110 28 24.0 1060 32 6 F+A 4 CON 63 F 157 51.0 117 28 23.0 884 41 25 F+A+C 5 CON 67 M 178 65.8 95 27 36.8 946 36 41 none 6 CGN 69 M 176 82.0 105 24 33.0 955 38 4 F 7 CON 67 F 169 59.5 125 22 23.7 1061 31 4 C 8 PCK 61 M 170 62.4 107 25 26.1 1140 36 17 F 9 CPN 70 M 163 60.9 103 30 29.7 990 37 31 F a Abbreviationsare: TBC, renal tuberculosis; CON, chronic glomerulonephritis; NSC, nephrosclerosis; PCK, polycystic kidney disease; CPN, chronic pyelonephritis; MAP, mean arterial blood pressure; F, furosemide; A, aipha-methyldopa; C, captopril. the supine position. All subjects were recumbent for at least 30 were accepted, red wicks being excluded. Wick fluid was mm before the injections were given. The measurements of isolatedby centrifugation under mineral oil [19] and colloid plasma and interstitial colloid osmotic pressure were performedosmotic pressure was measured by the osmometer mentioned in patients and normal subjects in the supine position and at theearlier. All the interstitial fluid pressure values represent the same time of the day. Both patients and normal subjects weremean of at least two (two to four) separate measurements of ambulatory until the blood test for plasma colloid osmoticwick fluid from two to four wicks. pressure was drawn. Plasma volume Plasma volume (PV) was determined as the In the patients, body fluid volumes and colloid osmoticinitial '251-albumin distribution space as previously described pressure in plasma and subcutaneous interstitial fluid were[14]. Values are given as ml per kg lean body mass (mllkg measured on day 1 in pre-dialysis state (48 to 72 hours afterLBM). hemodialysis). On days 2 and 3, ultrafiltration was performed in Blood volume (BV) BV was calculated from PV and hemato- order to bring the patient as near to dry-weight as possible, andcrit using a Fcell ratio (ratio of whole body hematocrit to large was followed by hemodialysis without transmembrane pressurevessel hematocrit) of 84% in normal subjects and 81% in the for two hours. Plasma colloid osmotic pressure was measureddialysis patients [11. Values are given as ml per kg lean body before, during and after ultrafiltration. The measurements per-mass (mllkg LBM). formed on day 1 were then repeated on day 4 in exactly the Extracellular fluid volume Extracellular fluid volume was same manner. measured by intravenous administration of radiosulfate as Ultrafiltration procedure Ultrafiltration treatment was per-previously described [14]. Values are given as ml per kg lean formed using a Oambro AK-b proportioning system with abody mass (mllkg LBM). Oambro-Lundia plate filter (11.5 t)(OambroIndustries, Bar- Interstitial fluid volume Interstitial fluid volume equals extra- rington, Illinois, USA). Ultrafiltrate was collected during treat-cellularfluid volume minus plasma volume and the values are ment and the volume measured. Infusions were not given given as ml per kg lean body mass (mllkg LBM). during ultrafiltration. Blood samples were collected from the Leanbody mass LBM wascalculated from body height and arterial blood line at the start, and after 30, 60, and 120 mm, and weightusing the formulas given by Womersley et al [21]. at end of ultrafiltration for measurements of plasma colloid Plasma refilling rate (PRR) PRR represent a measure of the osmotic pressure and hematocrit. fluid volume transport from the interstitium to the intravascular Colloidosmoticpressure A colloid osmometer (Departmentspace during ultrafiltration and the values are given as mllmin. ofPhysiology, University of Bergen, Norway) made for 5 gliter PRR was calculated using the following equation: samples with Amieon PM3O membranes was used [17]. The coefficient of variation within assays was 4.3% (N=12)and PRR =(UF-volume—PV)IUF-time between assays 4.9% (N=10). Interstitialcolloid osmotic pressure Subcutaneousinterstitial fluid was collected by the wick technique [18—20], Under where UF-volume is ultrafiltrate volume in ml, PV is the aseptic conditions four double nylon wicks (containing 600 calculated change in plasma volume during ultrafiltration in ml, filaments,diameter 1 mm) soaked in saline were sewn into and UF-time is the duration of ultrafiltration in mm. APV was subcutaneous tissue on the side of the thorax in a length of 5 to calculated as: 8 cm.